TTM
45.9%
YoY change
+9.05pp
Trough year (2008)
0.2%
Peak year (2025)
42.9%
Latest annual
42.9%
EBITDA Margin history chart for Eli Lilly (LLY) from 1985 to 2025
Latest: 42.9%
EBITDA Margin change chart for Eli Lilly (LLY) from 1985 to 2025
Latest: +9.05pp
EBITDA Margin history table for Eli Lilly (LLY) from 1985 to 2025
| 2025 | 42.9% | +9.05pp | ||
| 2024 | 33.8% | +8.70pp | ||
| 2023 | 25.1% | -5.24pp | ||
| 2022 | 30.3% | +1.94pp | ||
| 2021 | 28.4% | -7.92pp | ||
| 2020 | 36.3% | +5.41pp | ||
| 2019 | 30.9% | +5.17pp | ||
| 2018 | 25.7% | +5.22pp | ||
| 2017 | 20.5% | -3.31pp | ||
| 2016 | 23.8% | +1.88pp | ||
| 2015 | 21.9% | -1.14pp | ||
| 2014 | 23.1% | -9.34pp | ||
| 2013 | 32.4% | +1.25pp | ||
| 2012 | 31.2% | +2.73pp | ||
| 2011 | 28.4% | -6.39pp | ||
| 2010 | 34.8% | +3.16pp | ||
| 2009 | 31.7% | +31.46pp | ||
| 2008 | 0.2% | -31.19pp | ||
| 2007 | 31.4% | -0.00pp | ||
| 2006 | 31.4% | +1.53pp | ||
| 2005 | 29.9% | -0.84pp | ||
| 2004 | 30.7% | -1.48pp | ||
| 2003 | 32.2% | -2.30pp | ||
| 2002 | 34.5% | -1.76pp | ||
| 2001 | 36.3% | -0.53pp | ||
| 2000 | 36.8% | -1.24pp | ||
| 1999 | 38.0% | +2.14pp | ||
| 1998 | 35.9% | -1.02pp | ||
| 1997 | 36.9% | -0.07pp | ||
| 1996 | 37.0% | -0.51pp | ||
| 1995 | 37.5% | -1.51pp | ||
| 1994 | 39.0% | +22.71pp | ||
| 1993 | 16.3% | -8.42pp | ||
| 1992 | 24.7% | -11.41pp | ||
| 1991 | 36.1% | +1.70pp | ||
| 1990 | 34.4% | +1.03pp | ||
| 1989 | 33.4% | +2.65pp | ||
| 1988 | 30.7% | +9.35pp | ||
| 1987 | 21.4% | -6.51pp | ||
| 1986 | 27.9% | +0.36pp | ||
| 1985 | 27.5% | — |
- 202542.9%+9.05pp
- 202433.8%+8.70pp
- 202325.1%-5.24pp
- 202230.3%+1.94pp
- 202128.4%-7.92pp
- 202036.3%+5.41pp
- 201930.9%+5.17pp
- 201825.7%+5.22pp
- 201720.5%-3.31pp
- 201623.8%+1.88pp
- 201521.9%-1.14pp
- 201423.1%-9.34pp
- 201332.4%+1.25pp
- 201231.2%+2.73pp
- 201128.4%-6.39pp
- 201034.8%+3.16pp
- 200931.7%+31.46pp
- 20080.2%-31.19pp
- 200731.4%-0.00pp
- 200631.4%+1.53pp
- 200529.9%-0.84pp
- 200430.7%-1.48pp
- 200332.2%-2.30pp
- 200234.5%-1.76pp
- 200136.3%-0.53pp
- 200036.8%-1.24pp
- 199938.0%+2.14pp
- 199835.9%-1.02pp
- 199736.9%-0.07pp
- 199637.0%-0.51pp
- 199537.5%-1.51pp
- 199439.0%+22.71pp
- 199316.3%-8.42pp
- 199224.7%-11.41pp
- 199136.1%+1.70pp
- 199034.4%+1.03pp
- 198933.4%+2.65pp
- 198830.7%+9.35pp
- 198721.4%-6.51pp
- 198627.9%+0.36pp
- 198527.5%—
EBITDA Margin values are taken from Eli Lilly's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA Margin at Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported EBITDA margin is 45.9%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Eli Lilly (LLY) EBITDA margin totalled 42.86% – expanded 9.1 percentage points year-over-year.
The highest annual EBITDA margin of 42.86% was reported in 2025. The lowest in the available history was 0.21% in 2008.
Eli Lilly EBITDA Margin by Year
Eli Lilly EBITDA Margin 2025: 42.9%
In 2025, Eli Lilly reported EBITDA margin of 42.86%, expanded 9.1 percentage points from 2024. This figure represents the highest annual value in the available history.
Eli Lilly EBITDA Margin 2024: 33.8%
Eli Lilly EBITDA margin in 2024 was 33.81%, expanded 8.7 percentage points from 2023.
Eli Lilly EBITDA Margin 2023: 25.1%
2023's EBITDA margin for Eli Lilly came in at 25.11%, contracted 5.2 percentage points from 2022.
Eli Lilly EBITDA Margin 2022: 30.3%
Eli Lilly posted EBITDA margin of 30.34% in 2022, expanded 1.9 percentage points from 2021.
Eli Lilly EBITDA Margin 2021: 28.4%
Eli Lilly EBITDA margin in 2021 was 28.40%.
See more financial history for Eli Lilly (LLY).
Sector peers by EBITDA Margin
Healthcare peers of Eli Lilly (LLY), ranked by their latest EBITDA margin
| 55.4% | |
| 46.6% | |
| 34.6% | |
| 33.9% | |
| 30.3% | |
| 26.9% | |
| 24.7% | |
| 5.1% |
- 55.4%
- 46.6%
- 34.6%
- 33.9%
- 26.9%
Frequently asked questions
Eli Lilly (LLY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation